CLINICAL_TRIALS
trial_result
· 2014-04-23
Clinical Trial Update: Clinical Trial of CNS-targeted HAART (CIT2) [Phase 2, Phase 3]
Summary
CNS-targeted HAART trial CIT2 for HIV infection completed (Phase 2/Phase 3); results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of California, San Diego | Conditions: HIV Infections | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-04-23